Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Brian E Fink, Ashvinikumar V Gavai, John S Tokarski, Bindu Goyal, Raj Misra, Hai-Yun Xiao, S David Kimball, Wen-Ching Han, Derek Norris, Thomas E Spires, Dan You, Marco M Gottardis, Matthew V Lorenzi, Gregory D Vite
Index: Bioorg. Med. Chem. Lett. 16(6) , 1532-1536, (2006)
Full Text: HTML
Abstract
A novel series of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3) inhibitors has been identified. These inhibitors, based on a dibenzazocine core, exhibited picomolar to low nanomolar inhibition of 17beta-HSD3 in cell-free enzymatic as well as in cell-based transcriptional reporter assays.
Related Compounds
Related Articles:
2011-06-23
[J. Med. Chem. 54 , 4219-4233, (2011)]
2000-06-01
[Bioorg. Med. Chem. 8(6) , 1245-52, (2000)]
The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.
2006-01-15
[Bioorg. Med. Chem. Lett. 16(2) , 378-381, (2006)]
2001-01-01
[J. Org. Chem. 64(1) , 120-125, (1999)]
Enzymatic Baeyer-Villiger Oxidation of Benzo-Fused Ketones: Formation of Regiocomplementary Lactones. Rioz-Martinez A, et al.
[European J. Org. Chem. 2009(15) , 2526-2532, (2009)]